As members of the Children's Oncology Group, our physicians and nurses are involved in the development and management of protocols used internationally to treat children with cancer. This provides our patients with access to the most advanced clinical trials available for malignancies including leukemia, lymphoma, brain tumors, neuroblastoma, Wilm’s tumor and other kidney tumors, bone tumors, and sarcomas. It is through this participation by institutions worldwide that the cure rates for cancer have improved from a universally fatal disease to one that carries an 80% long-term survival rate.
The Pediatric Oncology Experimental Therapeutics Program was endowed by the Four Diamonds Fund in 2007 with the mission to identify approaches to increase the cure rate and reduce side effects of cancer treatment for children. The program supports the identification and validation of new targets for cancer-directed drugs and facilitates creation and testing of new therapies to treat childhood cancer. The Experimental Therapeutics Program endowment complements the research programs supported through the Four Diamonds Pediatric Cancer Research Center endowment.